Recombinant RelB Monoclonal Antibody

For reference only. Please follow the manual included in your kit for instructions.

Catalog Number
Western Blot with Recombinant RelB Monoclonal Antibody at dilution of 1:1000 dilution. Lane A: NIH-3T3 whole cell lysate.
Western Blot with Recombinant RelB Monoclonal Antibody at dilution of 1:1000 dilution. Lane A: NIH-3T3 whole cell lysate.
Add to Cart

For more information on our kits, please

Overview

Circle
Product Name
Recombinant RelB Monoclonal Antibody
Catalog Number
RD270083A
Clonality
Monoclonal
Purification Method
Protein A purification
Isotype
IgG;κ

Background

Circle
Was originally (PubMed:1577270) thought to inhibit the transcriptional activity of nuclear factor NF-kappa-B., domain:Both N- and C-terminal domains are required for transcriptional activation., NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric RelB-p50 and RelB-p52 complexes are transcriptional activators. RELB neither associates with DNA nor with RELA/p65 or REL. Stimulates promoter activity in the presence of NFKB2/p49., induction:By mitogens., PTM:Phosphorylation at 'Thr-103' and 'Ser-573' is followed by proteasomal degradation., similarity:Contains 1 RHD (Rel-like) domain., subunit:Component of the NF-kappa-B RelB-p50 complex. Component of the NF-kappa-B RelB-p52 complex. Self-associates, the interaction seems to be transient and may prevent degradation allowing for heterodimer formation with p50 or p52. Interacts with NFKB1/p50, NFKB2/p52 and NFKB2/p100. Interacts with NFKBID.

Immunogen Information

Circle
Immunogen
Recombinant Human RelB protein
Swissprot
Q01201
Synonyms
RELBI-RELIRELREL-BI RELNuclear factor of kappa light polypeptide gene enhancer in B cells 3Reticuloendotheliosis viral oncogene homolog BTranscription factor Rel BTranscription factor RelBv rel avian reticuloendotheliosis viral oncogene homolog B
Calculated MW
62 kDa
Observed MW
62 kDa

Applications

Circle
Reactivity
Tested Applications
WB
Conjugation
Unconjugated
Dilution
WB 1:2000-1:10000
Concentration
0.2 mg/mL
Storage Buffer
PBS; 50% glycerol; 0.05% Proclin 300; 0.05% protein protectant.
Storage Instructions
Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.

Your item has been successfully added to your cart .

Item # Price
Proceed to Cart
Never miss an update.

Sign up for our monthly newsletter to hear about exclusive sales and product tips and tricks.